C&EN, Vol. 89, n.5 (pp. 13-14, 16-19), 20118 February 2011
BUBENDORF, Switzerland (February 8, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, was featured in the weekly issue of Chemical and Engineering News (C&EN) dated January 31st, 2011. Ann M. Thayer, correspondent for C&EN interviewed Brian O’Neill, sales manager, CARBOGEN AMCIS for a C&EN cover story entitled, “Custom chemicals. Slowly recovering in 2010, contract manufacturers envision a path toward growth by responding to marketplace shifts.”
Chemical & Engineering News is a weekly magazine published by the American Chemical Society with a global circulation of 133,983, according to their website.
The article can be viewed on line: http://pubs.acs.org/cen/coverstory/89/8905cover.html
CARBOGEN AMCIS AG is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India.